Pfizer Inc.
PFE
$25.60
-$0.10-0.39%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 263.05% | -146.53% | -- | -- | 623.66% |
| Total Depreciation and Amortization | -3.01% | 0.12% | -- | -- | -9.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.67% | 767.74% | -- | -- | -120.48% |
| Change in Net Operating Assets | -208.93% | 4,516.67% | -- | -- | -165.58% |
| Cash from Operations | -51.10% | 16.19% | -- | -- | -65.26% |
| Capital Expenditure | 48.40% | -40.37% | -- | -- | 38.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.91% | 188.95% | -- | -- | 643.63% |
| Cash from Investing | 112.77% | -152.92% | -- | -- | 301.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 95.63% | -48,533.33% | -- | -- | 29.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -0.04% | -- | -- | -2.39% |
| Other Financing Activities | -545.45% | -12.82% | -- | -- | -2,442.86% |
| Cash from Financing | -579.19% | 124.06% | -- | -- | -2.21% |
| Foreign Exchange rate Adjustments | 280.00% | 150.00% | -- | -- | 75.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 385.79% | 34.33% | -- | -- | 931.11% |